Literature DB >> 20843707

Effective enrichment of prostate cancer stem cells from spheres in a suspension culture system.

Xinlan Fan1, Shanying Liu, Fang Su, Qiuhui Pan, Tianxin Lin.   

Abstract

BACKGROUND: Stem-like prostate cancer cells are also called prostate cancer stem cells (PrCSCs). These rare cells are supposed to be highly tumorigenic and to be involved in maintenance of tumor homeostasis and mediation of tumor metastasis. Methods for sorting PrCSCs are mainly based on sorting cells with the marker (CD133(+)/CD44(+)) or side population cells. However, CD133(+)/CD44(+) cells or side population cells are very rare or even undetectable. The scarcity of approaches for isolation and purification of PrCSCs is the main obstacle to studying PrCSCs.
METHODS: In the present study, suspension culture was used for enrichment of PrCSCs. And PrCSCs were verified by side population technology, drug sensitivity assays, and the molecular marker analysis of prostate cancer stem cell.
RESULTS: PC3 cells survived and formed spheres in nonadherent suspension culture. The percentage of CD44(+)/CD133(+) cells was 18-fold higher in the nonadherent sphere-forming cell population than in the adherent PC3 cell population (13.94% vs. 0.77%, respectively). This side population was increased to 3.1% in the nonadherent population but undetectable in adherent population. Resistance to cisplatin was higher in the nonadherent cells than adherent cells.
CONCLUSION: Suspension culture can be used to enrich for PrCSCs. This approach will aid prostate stem cell biology research and facilitate identification of novel therapeutic agents for prostate cancer.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20843707     DOI: 10.1016/j.urolonc.2010.03.019

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  39 in total

1.  Enhanced enrichment of prostate cancer stem-like cells with miniaturized 3D culture in liquid core-hydrogel shell microcapsules.

Authors:  Wei Rao; Shuting Zhao; Jianhua Yu; Xiongbin Lu; Debra L Zynger; Xiaoming He
Journal:  Biomaterials       Date:  2014-06-19       Impact factor: 12.479

Review 2.  Cancer stem cell detection and isolation.

Authors:  Meysam Moghbeli; Faezeh Moghbeli; Mohammad Mahdi Forghanifard; Mohammad Reza Abbaszadegan
Journal:  Med Oncol       Date:  2014-07-27       Impact factor: 3.064

3.  Blockage of neddylation modification stimulates tumor sphere formation in vitro and stem cell differentiation and wound healing in vivo.

Authors:  Xiaochen Zhou; Mingjia Tan; Mukesh K Nyati; Yongchao Zhao; Gongxian Wang; Yi Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-09       Impact factor: 11.205

Review 4.  Frequent gene products and molecular pathways altered in prostate cancer- and metastasis-initiating cells and their progenies and novel promising multitargeted therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  Mol Med       Date:  2011-05-20       Impact factor: 6.354

5.  Treatment of colon cancer with oncolytic herpes simplex virus in preclinical models.

Authors:  H Yang; T Peng; J Li; Y Wang; W Zhang; P Zhang; S Peng; T Du; Y Li; Q Yan; B Liu
Journal:  Gene Ther       Date:  2016-02-12       Impact factor: 5.250

6.  NOTCH1 signaling promotes chemoresistance via regulating ABCC1 expression in prostate cancer stem cells.

Authors:  Cheng Liu; Zhuohang Li; Liangkuan Bi; Kuiqing Li; Bangfen Zhou; Chen Xu; Jian Huang; Kewei Xu
Journal:  Mol Cell Biochem       Date:  2014-04-30       Impact factor: 3.396

7.  Doublecortin-like kinase 1 exhibits cancer stem cell-like characteristics in a human colon cancer cell line.

Authors:  Lianna Li; Charles F Bellows
Journal:  Chin J Cancer Res       Date:  2013-04       Impact factor: 5.087

8.  Enrichment of prostate cancer stem cells from primary prostate cancer cultures of biopsy samples.

Authors:  Shunqi Wang; Shengsong Huang; Xin Zhao; Qimin Zhang; Min Wu; Feng Sun; Gang Han; Denglong Wu
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

9.  Ecotropic viral integration site 1, a novel oncogene in prostate cancer.

Authors:  A Queisser; S Hagedorn; H Wang; T Schaefer; M Konantz; S Alavi; M Deng; W Vogel; A von Mässenhausen; G Kristiansen; S Duensing; J Kirfel; C Lengerke; S Perner
Journal:  Oncogene       Date:  2016-09-12       Impact factor: 9.867

10.  Increased chemosensitivity via targeting testicular nuclear receptor 4 (TR4)-Oct4-interleukin 1 receptor antagonist (IL1Ra) axis in prostate cancer CD133+ stem/progenitor cells to battle prostate cancer.

Authors:  Dong-Rong Yang; Xian-Fan Ding; Jie Luo; Yu-Xi Shan; Ronghao Wang; Shin-Jen Lin; Gonghui Li; Chiung-Kuei Huang; Jin Zhu; Yuhchyau Chen; Soo Ok Lee; Chawnshang Chang
Journal:  J Biol Chem       Date:  2013-04-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.